Metraipolis › archive › dc_89bcf96071fd

Quality of life improvements with setmelanotide treatment in acquired hypothalamic obesity: TRANSCEND trial interview results from US participants — Europe PMC PMID:42528856

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42528856
DOI: 10.3389/fnbeh.2026.1830070
License (as archived): solo-consultazione
Archived: 2026-10-18T06:57:38.660Z
SHA-256 of the archived text: aa90f868c479a6c36fa60e52544ae412e055f3cc30b821d45d0dd2546ced7fab
Stable URL of this page: https://metraipolis.com/documento/dc_89bcf96071fd

How to cite

Quality of life improvements with setmelanotide treatment in acquired hypothalamic obesity: TRANSCEND trial interview results from US participants — Europe PMC PMID:42528856 — Europe PMC (en), https://europepmc.org/article/MED/42528856 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_89bcf96071fd (Metraipolis archive dc_89bcf96071fd, sha256 aa90f868c479a6c36fa60e52544ae412e055f3cc30b821d45d0dd2546ced7fab)

BibTeX

@misc{dc89bcf96071fd,
  title = {Quality of life improvements with setmelanotide treatment in acquired hypothalamic obesity: TRANSCEND trial interview results from US participants — Europe PMC PMID:42528856},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42528856},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_89bcf96071fd; sha256 aa90f868c479a6c36fa60e52544ae412e055f3cc30b821d45d0dd2546ced7fab},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42528856. Agents can read the archived copy with the MCP tool read_document.